End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
Jun. 10 | Transcript : MedinCell S.A., 2024 Earnings Call, Jun 10, 2024 | |
Jun. 10 | Medincell: a 'new era' after a 'pivotal' 2023 | CF |
Sales 2024 | 9.03M 9.67M | Sales 2025 * | 36M 38.53M | Capitalization | 405M 434M |
---|---|---|---|---|---|
Net income 2024 | -25M -26.76M | Net income 2025 * | - 0 | EV / Sales 2024 | 30.5 x |
Net Debt 2024 * | 46.97M 50.27M | Net Debt 2025 * | 32M 34.25M | EV / Sales 2025 * | 12.1 x |
P/E ratio 2024 * |
-15.3
x | P/E ratio 2025 * |
-51
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.05% |
Latest transcript on MedinCell
Managers | Title | Age | Since |
---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 60 | 03-01-08 |
Stéphane Postic
DFI | Director of Finance/CFO | 50 | 23-08-31 |
Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sabri Markabi
BRD | Director/Board Member | - | 17-07-04 |
Tone Kvåle
BRD | Director/Board Member | 55 | 22-06-12 |
Virginie Lleu
BRD | Director/Board Member | - | 16-05-24 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |